Direct oral anticoagulant prescribing for atrial fibrillation: an Australian tertiary centre experience of ischaemic stroke complication
Underdosing of DOAC therapy has a significant impact on whether individuals develop ischaemic CVAs. Clinicians must be stringent in applying dose reductions based on established guidelines and must be aware to review dosing for all their DOAC patients.
Authors
- Krishnaa Sivapalan
- Cindy Yu
- Christopher Morris (ORCID: https://orcid.org/0000-0002-9916-507X)
- Vineel Lal
- Akashneel Lal
- Ian Hughes
Institutions
- Gold Coast Hospital (AU)
- Auckland City Hospital (NZ)
- Princess Alexandra Hospital (AU)
- Ipswich Hospital (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1111/imj.70325
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00